Xiaolan Deng

11.9k citations
65 papers · 9.4k · 11 hit papers · h-index 33

Impact in

    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • RNA Research and Splicing
    • Circular RNAs in diseases
    • Cancer-related molecular mechanisms research
    • Cancer, Hypoxia, and Metabolism

Papers in

Xiaolan Deng

64 papers receiving 9.3k citations

Xiaolan Deng's Hit Papers

The roles and implications of RNA m6A modification in cancer 2023 · 270 citations
2700+3+6Years since publication5001k1.5k2k

Peers

Xiaolan Deng
Comparison fields: 5 of 129
  • Molecular Biology 7.6k
  • Cancer Research 690
  • Hematology 316
  • Oncology 368
  • Genetics 111
Replace Nathan R. Wall with:
Nathan R. Wall United States
William H. Chappell United States
Jie Wu United States
Minjie Wei China
Jakub Rohlena Czechia
Jingxuan Pan China
Vivek M. Rangnekar United States
Ming Zhao United States
Hongmei Li China
Xiaolan Deng relative to Nathan R. Wall United States Nathan R. Wall's profile →
Citations per field
00.5×2×4×6×7.8×
Nathan R. Wall · 1×
Citations per year

Countries citing papers authored by Xiaolan Deng

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Deng more than expected).

Fields of papers citing papers by Xiaolan Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Deng. The network helps show where Xiaolan Deng may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaolan Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaolan Deng Line = papers co-authored together Xiaolan Deng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Hit paper breakdown →
20182336
2
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Hit paper breakdown →
2017941
3
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hit paper breakdown →
2017827
4
RNA N6-methyladenosine modification in cancers: current status and perspectives
Hit paper breakdown →
2018661
5
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Hit paper breakdown →
2020618
6
Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally
Hit paper breakdown →
2019558
7 2020310
8
The roles and implications of RNA m6A modification in cancer
Hit paper breakdown →
2023270
9
METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis
Hit paper breakdown →
2022266
10
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia
Hit paper breakdown →
2022263
11
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Hit paper breakdown →
2021257
12
FTO in cancer: functions, molecular mechanisms, and therapeutic implications
Hit paper breakdown →
2022190
13 2017173
14 2023139
15 2023131
16 2018112
17 2022112
18 202380
19 201669
20 201968

About Xiaolan Deng

Xiaolan Deng is a scholar working on Molecular Biology, Analytical Chemistry, Cancer Research, Hematology and Spectroscopy, having authored 65 papers that have together received 9.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (27 papers), Acute Myeloid Leukemia Research (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Analytical Chemistry and Chromatography (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Molecular Biology (7.6k citations), Cancer Research (690 citations), Hematology (316 citations), Oncology (368 citations) and Genetics (111 citations). Xiaolan Deng has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Jianjun Chen, Rui Jun Su, Huilin Huang, Hengyou Weng, Zejuan Li, Ying Qing, David Horne, Yusuke Nakamura, Minjie Wei and Yangchan Li. Their work appears in journals such as Cell stem cell, Journal of Separation Science, Cell, Nature Cell Biology and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact